Atlas Trials

Measles-Mumps-Rubella

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Measles-Mumps-Rubella

RecordFirmDate
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age (NCT02184572)GlaxoSmithKline2014-08-25
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age (NCT01621802)GlaxoSmithKline2012-06-21

Track Measles-Mumps-Rubella automatically

Every clearance here is in the API, with alerts when new ones post.